Table 5.

Recommended Surveillance for Individuals with Congenital Dyserythropoietic Anemia Type I

System/ConcernEvaluationFrequency
Anemia HemoglobinEvery 3-6 mos, more frequent at time of infections
Iron overload Bilirubin, iron, transferrin & serum ferritin concentrationEvery 6-12 mos beginning at age 10 yrs
Liver & myocardial T2-weighted MRIAnnually beginning at age 10 yrs (if available)
Biliary stones Abdominal ultrasoundAnnually beginning at age 5 yrs
Scoliosis Exam w/orthopedistAs needed
Osteoporosis Bone densitometryAs recommended by bone specialist
Vision issues Visual acuity, fundoscopic examAnnually beginning at age 40 yrs, earlier if symptomatic

From: Congenital Dyserythropoietic Anemia Type I

Cover of GeneReviews®
GeneReviews® [Internet].
Adam MP, Feldman J, Mirzaa GM, et al., editors.
Seattle (WA): University of Washington, Seattle; 1993-2024.
Copyright © 1993-2024, University of Washington, Seattle. GeneReviews is a registered trademark of the University of Washington, Seattle. All rights reserved.

GeneReviews® chapters are owned by the University of Washington. Permission is hereby granted to reproduce, distribute, and translate copies of content materials for noncommercial research purposes only, provided that (i) credit for source (http://www.genereviews.org/) and copyright (© 1993-2024 University of Washington) are included with each copy; (ii) a link to the original material is provided whenever the material is published elsewhere on the Web; and (iii) reproducers, distributors, and/or translators comply with the GeneReviews® Copyright Notice and Usage Disclaimer. No further modifications are allowed. For clarity, excerpts of GeneReviews chapters for use in lab reports and clinic notes are a permitted use.

For more information, see the GeneReviews® Copyright Notice and Usage Disclaimer.

For questions regarding permissions or whether a specified use is allowed, contact: ude.wu@tssamda.

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.